CO2-laser therapy and genitourinary syndrome of menopause: a systematic review and meta-analysis

M Filippini, I Porcari, AF Ruffolo… - The journal of sexual …, 2022 - academic.oup.com
Background Genitourinary syndrome of menopause (GSM) is a widespread condition with a
great impact on quality of life and self-image. Aim We aimed to systematically review the …

New innovations for the treatment of vulvovaginal atrophy: an up-to-date review

V Benini, AF Ruffolo, A Casiraghi, RS Degliuomini… - Medicina, 2022 - mdpi.com
Vulvovaginal atrophy (VVA) is a chronic progressive disease involving the female genital
apparatus and lower urinary tract. This condition is related to hypoestrogenism consequent …

Fractional CO2 laser versus promestriene and lubricant in genitourinary syndrome of menopause: a randomized clinical trial

CA Politano, L Costa-Paiva, LB Aguiar… - Menopause, 2019 - journals.lww.com
Objective: The aim of this study was to compare the effects of fractional CO 2 laser therapy,
promestriene, and vaginal lubricants on genitourinary syndrome treatment and sexual …

Vaginal laser therapy for GSM/VVA: where we stand now–a review by the EUGA Working Group on Laser

S Salvatore, AF Ruffolo, C Phillips, S Athanasiou… - …, 2023 - Taylor & Francis
Vulvovaginal atrophy (VVA) is a chronic progressive condition that involves the genital and
lower urinary tracts, related to the decrease of serum estrogenic levels when menopause …

CO2 laser and the genitourinary syndrome of menopause: a randomized sham-controlled trial

S Salvatore, E Pitsouni, T Grigoriadis, D Zacharakis… - …, 2021 - Taylor & Francis
Purpose This study aimed to clarify the efficacy of intravaginal CO2-laser treatment in
postmenopausal women with genitourinary syndrome of menopause (GSM). Materials and …

The evidence behind the use of LASER for genitourinary syndrome of menopause, vulvovaginal atrophy, urinary incontinence and lichen sclerosus: a state‐of‐the‐art …

OE Mortensen, SE Christensen… - Acta Obstetricia et …, 2022 - Wiley Online Library
In recent years, LASER has been introduced as a minimally invasive treatment for a broad
range of vaginal and vulvar symptoms and diseases. However, the efficacy and safety of …

Vaginal laser therapy for genitourinary syndrome of menopause–systematic review

E Mension, I Alonso, M Tortajada, I Matas, S Gómez… - Maturitas, 2022 - Elsevier
Background Genitourinary syndrome of menopause (GSM) can have a great impact on the
quality of life (QOL), and affects between 53.8% and 90% of postmenopausal women. The …

Laser therapy in the treatment of female urinary incontinence and genitourinary syndrome of menopause: an update

D Franić, I Fistonić - BioMed research international, 2019 - Wiley Online Library
Vaginal birth trauma is the leading cause of stress urinary incontinence (SUI) in women.
Also, the process of ageing and hormonal deprivation in postmenopause alters the …

Pilot study of fractional CO2 laser therapy for genitourinary syndrome of menopause in gynecologic cancer survivors

AM Quick, T Dockter, J Le-Rademacher, R Salani… - Maturitas, 2021 - Elsevier
Purpose The objectives of this study were to evaluate the feasibility and efficacy of fractional
CO 2 laser therapy in gynecologic cancer survivors. Methods This was a pilot, multi …

Pelvic radiation therapy induced vaginal stenosis: a review of current modalities and recent treatment advances

G Varytė, D Bartkevičienė - Medicina, 2021 - mdpi.com
Radiation-induced vaginal stenosis (VS) is a common side effect of pelvic radiotherapy (RT).
RT-induced VS may have various negative effects on women's quality of life, in particular …